MedCath (MDTH) Reports Q2 Adj-EPS of $0.31, Beats by 11c
More News related to MDTH
- Medcath Corp. (MDTH) Posts Q4 EPS of $0.04, Misses Estimates
- MedCath Corporation Reports Fourth Quarter Earnings
- MedCath Receives Licensure and Accreditation for New Hualapai Mountain Medical Center
- Trading Radar for 11/12: Wal-Mart (WMT), Blockbuster (BBI), Nordstrom (JWN), Walt Disney (DIS), Kohl's (KSS) Report
- MedCath Corporation to Hold Conference Call on Fourth Quarter Results
More News related to Earnings
- Highlights From SWHC Q2 Conference Call: First Qtr Reflected Results From Two Segments Under S&W Umbrella; Guides Below for Q3
- NASB Financial (NASB) Posts Q4 EPS of $0.77, Tops Views
- Highlights From Take-Two Interactive Softwares' (TTWO) Forecast Teleconference
- Saks (SKS) Restates Q3 EPS to $0.04, Up from $0.01
- Big Lots (BIG) Delivers With Strong Q3 Results and Guidance
MedCath Corporation (Nasdaq: MDTH) reports Q2 EPS of $0.31, ex-items, 11 cents better than the analyst estimate of $0.20. Revenue for the quarter was $158.9 million, versus the consensus of $158.64 million.
Related Categories
EarningsStocks Mentioned
+0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
